• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光固化乙二醇壳聚糖水凝胶用于卵巢癌药物输送。

Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery.

机构信息

Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju 61469, Korea.

Department of Surgery, Chonnam National University Medical School, Gwangju 61469, Korea.

出版信息

Mar Drugs. 2019 Jan 10;17(1):41. doi: 10.3390/md17010041.

DOI:10.3390/md17010041
PMID:30634553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6356222/
Abstract

In this study, we prepared an injectable drug delivery depot system based on a visible light-cured glycol chitosan (GC) hydrogel containing paclitaxel (PTX)-complexed beta-cyclodextrin (β-CD) (GC/CD/PTX) for ovarian cancer (OC) therapy using a tumor-bearing mouse model. The hydrogel depot system had a 23.8 Pa of storage modulus at 100 rad/s after visible light irradiation for 10 s. In addition, GC was swollen as a function of time. However, GC had no degradation with the time change. Eventually, the swollen GC matrix affected the releases of PTX and CD/PTX. GC/PTX and GC/CD/PTX exhibited a controlled release of PTX for 7 days. In addition, GC/CD/PTX had a rapid PTX release for 7 days due to improved water solubility of PTX through CD/PTX complex. In vitro cell viability tests showed that GC/CD/PTX had a lower cell viability percentage than the free PTX solution and GC/PTX. Additionally, GC/CD/PTX resulted in a superior antitumor effect against OC. Consequently, we suggest that the GC/CD system might have clinical potential for OC therapy by improving the water solubility of PTX, as PTX is included into the cavity of β-CD.

摘要

在这项研究中,我们制备了一种基于可见光固化的壳聚糖(GC)水凝胶的可注射药物输送库系统,该水凝胶中含有紫杉醇(PTX)-β-环糊精(β-CD)复合物(GC/CD/PTX),用于使用荷瘤小鼠模型进行卵巢癌(OC)治疗。水凝胶库系统在可见光照射 10 秒后,在 100 rad/s 下具有 23.8 Pa 的存储模量。此外,GC 随时间而溶胀。然而,GC 随时间变化没有降解。最终,溶胀的 GC 基质影响了 PTX 和 CD/PTX 的释放。GC/PTX 和 GC/CD/PTX 表现出 7 天的 PTX 控制释放。此外,由于通过 CD/PTX 复合物提高了 PTX 的水溶性,GC/CD/PTX 在 7 天内迅速释放 PTX。体外细胞活力测试表明,GC/CD/PTX 的细胞活力百分比低于游离 PTX 溶液和 GC/PTX。此外,GC/CD/PTX 对 OC 具有更好的抗肿瘤作用。因此,我们建议 GC/CD 系统通过提高 PTX 的水溶性,将 PTX 包含在 β-CD 的腔中,可能具有 OC 治疗的临床潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/910600bfa09f/marinedrugs-17-00041-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/1876d4703492/marinedrugs-17-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/91c0f3c9acdd/marinedrugs-17-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/8fe0ec87b7ee/marinedrugs-17-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/9880209f8f9d/marinedrugs-17-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/7155f64c3736/marinedrugs-17-00041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/3c7c25529f03/marinedrugs-17-00041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/75c41df2f373/marinedrugs-17-00041-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/910600bfa09f/marinedrugs-17-00041-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/1876d4703492/marinedrugs-17-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/91c0f3c9acdd/marinedrugs-17-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/8fe0ec87b7ee/marinedrugs-17-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/9880209f8f9d/marinedrugs-17-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/7155f64c3736/marinedrugs-17-00041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/3c7c25529f03/marinedrugs-17-00041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/75c41df2f373/marinedrugs-17-00041-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/6356222/910600bfa09f/marinedrugs-17-00041-g008.jpg

相似文献

1
Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery.光固化乙二醇壳聚糖水凝胶用于卵巢癌药物输送。
Mar Drugs. 2019 Jan 10;17(1):41. doi: 10.3390/md17010041.
2
Visible Light-Cured Glycol Chitosan Hydrogel Containing a Beta-Cyclodextrin-Curcumin Inclusion Complex Improves Wound Healing In Vivo.含β-环糊精-姜黄素包合物的可见光固化乙二醇壳聚糖水凝胶可促进体内伤口愈合。
Molecules. 2017 Sep 10;22(9):1513. doi: 10.3390/molecules22091513.
3
Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro.紫杉醇的自组装肽水凝胶原位形成的控制释放及其体外抗肿瘤研究。
Int J Nanomedicine. 2011;6:2143-53. doi: 10.2147/IJN.S24038. Epub 2011 Sep 27.
4
Hydrogel-Mediated DOX⋅HCl/PTX Delivery System for Breast Cancer Therapy.水凝胶介导的 DOX⋅HCl/PTX 递药系统用于乳腺癌治疗。
Int J Mol Sci. 2019 Sep 20;20(19):4671. doi: 10.3390/ijms20194671.
5
Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.基于高固含量mPECT纳米颗粒和环糊精的超分子水凝胶用于局部和持续药物递送。
Biomater Sci. 2017 Mar 28;5(4):698-706. doi: 10.1039/c6bm00889e.
6
Injectable poly(organophosphazene) hydrogel system for effective paclitaxel and doxorubicin combination therapy.用于有效进行紫杉醇和阿霉素联合治疗的可注射聚(有机磷腈)水凝胶系统
J Drug Target. 2014 Sep;22(8):761-7. doi: 10.3109/1061186X.2014.921923. Epub 2014 Jun 17.
7
Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.基于泊洛沙姆 407 的温敏性胶束-水凝胶杂化系统用于紫杉醇的局部递送。
J Pharm Sci. 2013 Aug;102(8):2707-17. doi: 10.1002/jps.23649. Epub 2013 Jul 9.
8
Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study.可注射的可见光固化壳聚糖水凝胶用于体内局部癌症治疗的抗癌药物控释:一项可行的研究。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):874-882. doi: 10.1080/21691401.2018.1470529. Epub 2018 May 11.
9
Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.水凝胶低聚物偶联的壳聚糖载紫杉醇:合成、表征及体内分布。
J Control Release. 2009 Dec 16;140(3):210-7. doi: 10.1016/j.jconrel.2009.06.015. Epub 2009 Jun 26.
10
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.载紫杉醇纳米晶的新型温敏水凝胶系统:高载药量、持续药物释放和延长局部滞留时间,保证更好的疗效和更低的毒性。
J Control Release. 2014 Jan 28;174:161-70. doi: 10.1016/j.jconrel.2013.10.026.

引用本文的文献

1
Revolutionizing Cancer Care: The Role of 3D Printing in Personalized Oncology.变革癌症护理:3D打印在个性化肿瘤学中的作用。
ACS Omega. 2025 Aug 25;10(35):39350-39370. doi: 10.1021/acsomega.5c01642. eCollection 2025 Sep 9.
2
Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy.基于聚糖的支架和纳米颗粒作为癌症治疗中的药物传递系统。
Front Immunol. 2024 May 10;15:1395187. doi: 10.3389/fimmu.2024.1395187. eCollection 2024.
3
Histological evaluation of the regenerative potential of a novel photocrosslinkable gelatin-treated dentin matrix hydrogel in direct pulp capping: an animal study.

本文引用的文献

1
The Cocktail Effect of BMP-2 and TGF-β1 Loaded in Visible Light-Cured Glycol Chitosan Hydrogels for the Enhancement of Bone Formation in a Rat Tibial Defect Model.载有 BMP-2 和 TGF-β1 的可见光固化乙二醇壳聚糖水凝胶的鸡尾酒效应增强大鼠胫骨缺损模型中的骨形成。
Mar Drugs. 2018 Sep 25;16(10):351. doi: 10.3390/md16100351.
2
A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment in vitro and in vivo.基于可见光固化壳聚糖和盐酸多柔比星的局部药物递送系统,用于甲状腺癌的体内外治疗。
Drug Deliv. 2018 Nov;25(1):1664-1671. doi: 10.1080/10717544.2018.1507058.
3
新型光交联明胶处理牙本质基质水凝胶用于直接盖髓的再生潜力的组织学评价:一项动物研究。
BMC Oral Health. 2024 Jan 19;24(1):114. doi: 10.1186/s12903-024-03868-9.
4
Photocrosslinkable gelatin-treated dentin matrix hydrogel as a novel pulp capping agent for dentin regeneration: I. synthesis, characterizations and grafting optimization.光交联明胶处理牙本质基质水凝胶作为一种新型牙髓覆盖剂用于牙本质再生:I. 合成、表征和接枝优化。
BMC Oral Health. 2023 Aug 4;23(1):536. doi: 10.1186/s12903-023-03236-z.
5
BioMOF-Based Anti-Cancer Drug Delivery Systems.基于生物金属有机框架的抗癌药物递送系统
Nanomaterials (Basel). 2023 Mar 6;13(5):953. doi: 10.3390/nano13050953.
6
Fabrication and Evaluation of Gellan Gum/Hyaluronic Acid Hydrogel for Retinal Tissue Engineering Biomaterial and the Influence of Substrate Stress Relaxation on Retinal Pigment Epithelial Cells.藻酸钙/透明质酸水凝胶的制备及在视网膜组织工程生物材料中的评价及其基底的应变速率松弛对视网膜色素上皮细胞的影响。
Molecules. 2022 Aug 27;27(17):5512. doi: 10.3390/molecules27175512.
7
Chitin and Chitosan: Prospective Biomedical Applications in Drug Delivery, Cancer Treatment, and Wound Healing.几丁质和壳聚糖:药物传递、癌症治疗和伤口愈合方面有前景的生物医学应用。
Mar Drugs. 2022 Jul 17;20(7):460. doi: 10.3390/md20070460.
8
Bioengineering trends in female reproduction: a systematic review.女性生殖的生物工程趋势:系统评价。
Hum Reprod Update. 2022 Nov 2;28(6):798-837. doi: 10.1093/humupd/dmac025.
9
Novel Gels: An Emerging Approach for Delivering of Therapeutic Molecules and Recent Trends.新型凝胶:一种用于递送治疗性分子的新兴方法及近期趋势
Gels. 2022 May 19;8(5):316. doi: 10.3390/gels8050316.
10
Hydrogels for localized chemotherapy of liver cancer: a possible strategy for improved and safe liver cancer treatment.水凝胶用于肝癌局部化疗:改善和安全治疗肝癌的一种可能策略。
Drug Deliv. 2022 Dec;29(1):1457-1476. doi: 10.1080/10717544.2022.2070299.
Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
聚赖氨酸基纳米粒子的制备及其载姜黄素的 pH 敏感性释放用于肝癌的体外和体内靶向成像和治疗。
Drug Deliv. 2018 Nov;25(1):950-960. doi: 10.1080/10717544.2018.1461957.
4
Intratumoral Delivery of Doxorubicin on Folate-Conjugated Graphene Oxide by In-Situ Forming Thermo-Sensitive Hydrogel for Breast Cancer Therapy.通过原位形成热敏水凝胶将阿霉素递送至叶酸偶联氧化石墨烯用于乳腺癌治疗
Nanomaterials (Basel). 2017 Nov 14;7(11):388. doi: 10.3390/nano7110388.
5
β-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel.基于β-环糊精包合络合作用的可生物降解自组装大分子胶束用于紫杉醇递送
PLoS One. 2016 Mar 10;11(3):e0150877. doi: 10.1371/journal.pone.0150877. eCollection 2016.
6
Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.用于紫杉醇递送以克服耐药性的卵巢癌靶向透明质酸纳米粒子系统。
Drug Deliv. 2016 Jun;23(5):1810-7. doi: 10.3109/10717544.2015.1101792. Epub 2015 Nov 4.
7
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.紫杉醇及其在卵巢癌治疗中不断演变的作用。
Biomed Res Int. 2015;2015:413076. doi: 10.1155/2015/413076. Epub 2015 Jun 7.
8
Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?难溶性药物从纳米颗粒中的释放动力学研究:我们做得对吗?
Mol Pharm. 2015 Mar 2;12(3):997-1003. doi: 10.1021/mp500817h. Epub 2015 Feb 17.
9
A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery.一种用于瘤内给药的新型载阿霉素原位形成凝胶,其基于高浓度磷脂。
Mol Pharm. 2014 Oct 6;11(10):3378-85. doi: 10.1021/mp500019p. Epub 2014 Apr 25.
10
Nanocarriers for the targeted treatment of ovarian cancers.用于卵巢癌靶向治疗的纳米载体。
Biomaterials. 2013 Jan;34(4):1073-101. doi: 10.1016/j.biomaterials.2012.10.055. Epub 2012 Nov 20.